Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PW Medtech Group's share price for the quarter that ended in Dec. 2023 was HK$0.82. PW Medtech Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,565.6 Mil. Therefore, PW Medtech Group's market cap for the quarter that ended in Dec. 2023 was HK$1,283.8 Mil.
PW Medtech Group's quarterly market cap
declined
from Dec. 2022 (HK$986.3 Mil) to Jun. 2023 (HK$814.1 Mil) but then
increased
from Jun. 2023 (HK$814.1 Mil) to Dec. 2023 (HK$1,283.8 Mil).
PW Medtech Group's annual market cap
declined
from Dec. 2021 (HK$1,569.3 Mil) to Dec. 2022 (HK$986.3 Mil) but then
increased
from Dec. 2022 (HK$986.3 Mil) to Dec. 2023 (HK$1,283.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PW Medtech Group's Enterprise Value for Today is HK$-169.1 Mil.
PW Medtech Group Market Cap Historical Data
The historical data trend for PW Medtech Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PW Medtech Group's Market Cap
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Market Cap distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Market Cap falls into.
PW Medtech Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PW Medtech Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (HKSE:01358) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PW Medtech Group Market Cap Related Terms
Thank you for viewing the detailed overview of PW Medtech Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
PW Medtech Group (HKSE:01358) Business Description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01358 has been successfully added to your 